.jpg)
[ad_1]
An Oxford vaccine is being administered to a volunteer. However, the identity or information of the person who became ill has not been released. This image was previously published by Oxford.
Trials of the third (last) phase of the coronavirus vaccine developed by the University of Oxford have been temporarily suspended. In Britain, a recipient of the vaccine became ill and for now they have had to make that decision. However, no information was provided on the type of illness of the person who fell ill.
According to the BBC, the man who fell ill has been kept under observation. AstraZeneca, the University of Oxford’s partner in vaccine production, expects the trial to resume soon.
According to the information received, this vaccine from Oxford and AstraZeneca has been the most responsive to the coronary vaccine.
This is the third phase trial of this corona vaccine. Previously, the first and second phase tests were completed successfully. In the third phase, the vaccine is being applied to about 30,000 people in various countries around the world. With the success of this step, the Oxford vaccine will be ready for commercialization.
Although the trial was postponed, AstraZeneca called it a “routine” activity. This, they say, happens in large clinical trials.
A spokesman for the University of Oxford said: “Some people get sick during large trials. In such cases, their overall condition is monitored separately. An attempt was made to find out whether the vaccine had influenced their illness.
Oxford vaccine trials are underway in various parts of the world. Oxford authorities say trials will be closed everywhere until the crown vaccine on the man’s disease is known in detail. If you want to start the trial after knowing the physical condition of the individual, you need permission from the regulatory body.
Although there is no information on the physical condition of the sick person in this case, the interested parties hope that he will recover soon and the trial can be started.
Source: BBC
[ad_2]
